| NCT04216732 |
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management |
https://ClinicalTrials.gov/show/NCT04216732 |
Recruiting |
M.D. Anderson Cancer Center |
2022-09-01 |
| NCT03408769 |
Metastatic Breast Carcinoma and Women Sexual Quality of Life |
https://ClinicalTrials.gov/show/NCT03408769 |
Completed |
Institut de Cancérologie de Lorraine |
2018-04-04 |
| NCT03405909 |
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study |
https://ClinicalTrials.gov/show/NCT03405909 |
Recruiting |
University Hospital Erlangen |
2020-02-29 |
| NCT03370861 |
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes |
https://ClinicalTrials.gov/show/NCT03370861 |
Recruiting |
Washington University School of Medicine |
2022-12-31 |
| NCT02024035 |
Protocole Advanced RadioTherapy ORL |
https://ClinicalTrials.gov/show/NCT02024035 |
Completed |
Centre Leon Berard |
2012-03-31 |
| NCT04245410 |
Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04245410 |
Recruiting |
Universidad de Extremadura |
2020-03-01 |
| NCT03364907 |
Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy |
https://ClinicalTrials.gov/show/NCT03364907 |
Active, not recruiting |
Radboud University |
2019-06-08 |
| NCT04106349 |
Observational Real-life Study of Cabozantinib in Advanced Renal Cell Carcinoma (RCC) |
https://ClinicalTrials.gov/show/NCT04106349 |
Recruiting |
Ipsen |
2023-01-30 |
| NCT03822988 |
ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS |
https://ClinicalTrials.gov/show/NCT03822988 |
Recruiting |
Central Hospital, Nancy, France |
2019-06-20 |
| NCT03356535 |
Metabolic Signature of Healthy Lifestyle and HCC |
https://ClinicalTrials.gov/show/NCT03356535 |
Completed |
International Agency for Research on Cancer |
2017-09-15 |
| NCT03331874 |
RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03331874 |
Recruiting |
Norfolk and Norwich University Hospitals NHS Foundation Trust |
2019-12-31 |
| NCT03325738 |
Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study |
https://ClinicalTrials.gov/show/NCT03325738 |
Completed |
Centre Antoine Lacassagne |
2017-06-30 |
| NCT03314051 |
Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA |
https://ClinicalTrials.gov/show/NCT03314051 |
Completed |
Taichung Veterans General Hospital |
2013-05-01 |
| NCT03305133 |
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) |
https://ClinicalTrials.gov/show/NCT03305133 |
Completed |
Groupe Francais De Pneumo-Cancerologie |
2018-09-14 |
| NCT03295006 |
A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC |
https://ClinicalTrials.gov/show/NCT03295006 |
Recruiting |
BTG International Inc. |
2019-11-30 |
| NCT03289273 |
Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) |
https://ClinicalTrials.gov/show/NCT03289273 |
Active, not recruiting |
Bayer |
2022-02-01 |
| NCT03296826 |
Prospective Cohort Study of Variant Carriers With BRCA1 or BRCA2 |
https://ClinicalTrials.gov/show/NCT03296826 |
Recruiting |
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
2032-03-31 |
| NCT03290001 |
The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT03290001 |
Recruiting |
Sun Yat-sen University |
2022-09-20 |
| NCT03291028 |
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma |
https://ClinicalTrials.gov/show/NCT03291028 |
Recruiting |
Fox Chase Cancer Center |
2020-12-31 |
| NCT03290989 |
Itch and Pain Characteristics in Skin Carcinomas |
https://ClinicalTrials.gov/show/NCT03290989 |
Completed |
University Hospital, Brest |
2015-04-01 |
| NCT03253939 |
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer |
https://ClinicalTrials.gov/show/NCT03253939 |
Completed |
Hospices Civils de Lyon |
2017-07-01 |
| NCT03256877 |
Detecting Transitional Cell Carcinoma From Haematuria |
https://ClinicalTrials.gov/show/NCT03256877 |
Completed |
Hull University Teaching Hospitals NHS Trust |
2018-05-28 |
| NCT03254121 |
Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response |
https://ClinicalTrials.gov/show/NCT03254121 |
Recruiting |
Karolinska Institutet |
2021-01-01 |
| NCT03240835 |
The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients |
https://ClinicalTrials.gov/show/NCT03240835 |
Active, not recruiting |
Sun Yat-sen University |
2018-12-31 |
| NCT03226886 |
TRACERx Renal (TRAcking Renal Cell Carcinoma Evolution Through Therapy (Rx)) |
https://ClinicalTrials.gov/show/NCT03226886 |
Recruiting |
Royal Marsden NHS Foundation Trust |
2023-09-01 |
| NCT03211377 |
Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma |
https://ClinicalTrials.gov/show/NCT03211377 |
Recruiting |
Anyang Tumor Hospital |
2019-03-29 |
| NCT03200171 |
Effect of DAAs on Behavior of HCC in HCV Patients |
https://ClinicalTrials.gov/show/NCT03200171 |
Recruiting |
Al-Azhar University |
2019-08-31 |
| NCT03197155 |
Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence |
https://ClinicalTrials.gov/show/NCT03197155 |
Completed |
Hospices Civils de Lyon |
2017-01-31 |
| NCT03162198 |
Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT03162198 |
Completed |
Institute of Liver and Biliary Sciences, India |
2018-10-31 |
| NCT03163186 |
Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial). |
https://ClinicalTrials.gov/show/NCT03163186 |
Completed |
Medical University of South Carolina |
2016-04-20 |
| NCT03160209 |
HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi |
https://ClinicalTrials.gov/show/NCT03160209 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-07-31 |
| NCT03161145 |
A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread |
https://ClinicalTrials.gov/show/NCT03161145 |
Completed |
Bristol-Myers Squibb |
2017-08-31 |
| NCT03140176 |
Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy. |
https://ClinicalTrials.gov/show/NCT03140176 |
Recruiting |
Pfizer |
2020-12-30 |
| NCT03137706 |
Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer |
https://ClinicalTrials.gov/show/NCT03137706 |
Recruiting |
University of Southern California |
2021-02-14 |
| NCT03132727 |
Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03132727 |
Completed |
Hospices Civils de Lyon |
2019-11-22 |
| NCT03109457 |
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03109457 |
Completed |
Cairo University |
2018-02-07 |
| NCT03091465 |
Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib |
https://ClinicalTrials.gov/show/NCT03091465 |
Completed |
Spanish Oncology Genito-Urinary Group |
2017-04-17 |
| NCT03092830 |
Molecular Characterization of Cutaneous Tumors |
https://ClinicalTrials.gov/show/NCT03092830 |
Recruiting |
Rabin Medical Center |
2020-08-07 |
| NCT03092739 |
A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens |
https://ClinicalTrials.gov/show/NCT03092739 |
Completed |
Hoffmann-La Roche |
2018-01-08 |
| NCT03088423 |
HCC Response Assessment by MRI After SBRT |
https://ClinicalTrials.gov/show/NCT03088423 |
Completed |
Institut de Cancérologie de Lorraine |
2013-04-01 |
| NCT03053661 |
Immune Response Evaluation to Curative Conventional Therapy |
https://ClinicalTrials.gov/show/NCT03053661 |
Active, not recruiting |
University of Ulm |
2020-08-31 |
| NCT03053596 |
LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) |
https://ClinicalTrials.gov/show/NCT03053596 |
Completed |
Terumo Europe N.V. |
2019-04-01 |
| NCT03034850 |
Thrombin Generation and Platelet Activation in CRS/HIPEC |
https://ClinicalTrials.gov/show/NCT03034850 |
Completed |
Ziekenhuis Oost-Limburg |
2016-07-31 |
| NCT03013920 |
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma |
https://ClinicalTrials.gov/show/NCT03013920 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2018-04-30 |
| NCT03010150 |
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT03010150 |
Recruiting |
M.D. Anderson Cancer Center |
2019-12-31 |
| NCT02990351 |
Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt |
https://ClinicalTrials.gov/show/NCT02990351 |
Completed |
Ain Shams University |
2015-12-31 |
| NCT03232593 |
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) |
https://ClinicalTrials.gov/show/NCT03232593 |
Recruiting |
Hoffmann-La Roche |
2023-01-11 |
| NCT02940639 |
Real-Life Efficacy and Safety of Nivolumab in Patients With Advanced/Metastatic Renal Cell Carcinoma After Prior Therapy |
https://ClinicalTrials.gov/show/NCT02940639 |
Recruiting |
Bristol-Myers Squibb |
2024-10-31 |
| NCT02941861 |
Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery |
https://ClinicalTrials.gov/show/NCT02941861 |
Completed |
Chulabhorn Hospital |
2016-08-31 |
| NCT02908178 |
Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ |
https://ClinicalTrials.gov/show/NCT02908178 |
Completed |
Yale University |
2018-06-01 |
| NCT02880306 |
Hepatocellular Carcinoma and Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02880306 |
Completed |
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
2016-03-31 |
| NCT02879968 |
Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT02879968 |
Completed |
Prince of Songkla University |
2018-08-31 |
| NCT02878109 |
DCE-MRI for Assessment of Response to TACE of HCC |
https://ClinicalTrials.gov/show/NCT02878109 |
Completed |
Centre hospitalier de l’Université de Montréal (CHUM) |
2018-12-31 |
| NCT02854228 |
PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon |
https://ClinicalTrials.gov/show/NCT02854228 |
Recruiting |
Hospices Civils de Lyon |
2015-12-31 |
| NCT02848768 |
Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02848768 |
Completed |
Rennes University Hospital |
2015-03-31 |
| NCT02852343 |
One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02852343 |
Completed |
Rennes University Hospital |
2016-12-21 |
| NCT02848638 |
Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization |
https://ClinicalTrials.gov/show/NCT02848638 |
Completed |
University of Washington |
2016-03-31 |
| NCT02791750 |
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma |
https://ClinicalTrials.gov/show/NCT02791750 |
Completed |
Institut de Cancérologie de Lorraine |
2017-06-03 |
| NCT02785835 |
Hepatocellular Carcinoma in HIV-infected Patients |
https://ClinicalTrials.gov/show/NCT02785835 |
Recruiting |
Hospital Universitario de Valme |
2016-12-31 |
| NCT02781389 |
Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions |
https://ClinicalTrials.gov/show/NCT02781389 |
Active, not recruiting |
University Hospital, Essen |
2021-04-30 |
| NCT02778191 |
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02778191 |
Completed |
University Medical Center Groningen |
2017-03-31 |
| NCT02776644 |
Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan |
https://ClinicalTrials.gov/show/NCT02776644 |
Completed |
Pfizer |
2017-12-30 |
| NCT02757846 |
Radiomics of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02757846 |
Enrolling by invitation |
Chinese Academy of Sciences |
2022-03-31 |
| NCT02732665 |
Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02732665 |
Recruiting |
Chalmers University of Technology |
2019-03-31 |
| NCT02732652 |
Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02732652 |
Recruiting |
Chalmers University of Technology |
2019-03-31 |
| NCT02730611 |
Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02730611 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-10-31 |
| NCT02724345 |
Postoperative Adjuvant TACE Treatment in CK18 Positive Patients |
https://ClinicalTrials.gov/show/NCT02724345 |
Completed |
Eastern Hepatobiliary Surgery Hospital |
2015-06-30 |
| NCT02700659 |
The Cxbladder Monitoring Study |
https://ClinicalTrials.gov/show/NCT02700659 |
Completed |
Pacific Edge Limited |
2016-09-23 |
| NCT02674009 |
Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC) |
https://ClinicalTrials.gov/show/NCT02674009 |
Completed |
Hoffmann-La Roche |
2019-03-31 |
| NCT02670122 |
Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC |
https://ClinicalTrials.gov/show/NCT02670122 |
Completed |
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz |
2018-11-30 |
| NCT02672254 |
New Strategies Against Cutaneous Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02672254 |
Completed |
Corporacion Parc Tauli |
2016-01-31 |
| NCT02664883 |
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer |
https://ClinicalTrials.gov/show/NCT02664883 |
Recruiting |
University of Southern California |
2020-09-08 |
| NCT02663583 |
Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell |
https://ClinicalTrials.gov/show/NCT02663583 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT02649569 |
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02649569 |
Completed |
Albert Einstein College of Medicine |
2017-07-31 |
| NCT02643173 |
Hepatocellular Carcinoma Recurrence and Anesthesia |
https://ClinicalTrials.gov/show/NCT02643173 |
Completed |
Seoul National University Bundang Hospital |
2019-06-30 |
| NCT02628379 |
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary |
https://ClinicalTrials.gov/show/NCT02628379 |
Completed |
Foundation Medicine |
2017-03-31 |
| NCT02613156 |
Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02613156 |
Completed |
Sun Yat-sen University |
2015-10-31 |
| NCT02607605 |
A Prospective, Observational Trial on the Diagnostic and Prognostic of LM |
https://ClinicalTrials.gov/show/NCT02607605 |
Recruiting |
Sun Yat-sen University |
2019-12-31 |
| NCT02604472 |
Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT02604472 |
Completed |
Sun Yat-sen University |
2013-06-30 |
| NCT02597426 |
Nasopharyngeal Carcinoma Post IMRT |
https://ClinicalTrials.gov/show/NCT02597426 |
Active, not recruiting |
University Health Network, Toronto |
2020-09-30 |
| NCT02575547 |
Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients |
https://ClinicalTrials.gov/show/NCT02575547 |
Active, not recruiting |
Sun Yat-sen University |
2016-09-30 |
| NCT03148665 |
Saliva-based Detection of CD44 |
https://ClinicalTrials.gov/show/NCT03148665 |
Active, not recruiting |
University of California, San Diego |
2019-04-10 |
| NCT04353765 |
Non - Interventional, Retrospective Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors |
https://ClinicalTrials.gov/show/NCT04353765 |
Recruiting |
Ipsen |
2020-12-30 |
| NCT00046189 |
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum |
https://ClinicalTrials.gov/show/NCT00046189 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03398980 |
Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy |
https://ClinicalTrials.gov/show/NCT03398980 |
Completed |
Sun Yat-sen University |
2017-01-10 |
| NCT02552745 |
Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization |
https://ClinicalTrials.gov/show/NCT02552745 |
Completed |
Sun Yat-sen University |
2015-03-31 |
| NCT02541149 |
Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02541149 |
Completed |
Ain Shams University |
2015-06-30 |
| NCT02543476 |
SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) |
https://ClinicalTrials.gov/show/NCT02543476 |
Completed |
AstraZeneca |
2016-11-14 |
| NCT02537743 |
Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02537743 |
Active, not recruiting |
iOMEDICO AG |
2020-12-31 |
| NCT02535026 |
An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants |
https://ClinicalTrials.gov/show/NCT02535026 |
Completed |
Hoffmann-La Roche |
2013-12-31 |
| NCT02506816 |
Preoperative Olaparib Endometrial Carcinoma Study (POLEN) |
https://ClinicalTrials.gov/show/NCT02506816 |
Completed |
MedSIR |
2018-07-31 |
| NCT02501993 |
Nasopharyngeal Carcinoma Screening in Zhongshan City |
https://ClinicalTrials.gov/show/NCT02501993 |
Recruiting |
Zhongshan People’s Hospital, Guangdong, China |
2022-03-31 |
| NCT02410603 |
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer |
https://ClinicalTrials.gov/show/NCT02410603 |
Recruiting |
Mayo Clinic |
2020-06-30 |
| NCT02412579 |
Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation |
https://ClinicalTrials.gov/show/NCT02412579 |
Active, not recruiting |
Baylor Research Institute |
2020-05-15 |
| NCT02370303 |
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System |
https://ClinicalTrials.gov/show/NCT02370303 |
Completed |
Mayo Clinic |
2016-07-09 |
| NCT02370277 |
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer |
https://ClinicalTrials.gov/show/NCT02370277 |
Completed |
University of Southern California |
2016-06-15 |
| NCT02365844 |
Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT02365844 |
Completed |
Stanford University |
2018-08-27 |
| NCT02366286 |
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants |
https://ClinicalTrials.gov/show/NCT02366286 |
Active, not recruiting |
Mayo Clinic |
2022-12-31 |
| NCT02364024 |
Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal Carcinomas |
https://ClinicalTrials.gov/show/NCT02364024 |
Completed |
Federation Francophone de Cancerologie Digestive |
2009-05-31 |
| NCT02358070 |
Epidemiologic Study of Hepatocellular Carcinoma in the US |
https://ClinicalTrials.gov/show/NCT02358070 |
Completed |
Stanford University |
2016-09-01 |
| NCT02355262 |
CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers |
https://ClinicalTrials.gov/show/NCT02355262 |
Active, not recruiting |
OHSU Knight Cancer Institute |
2020-06-30 |
| NCT02315755 |
Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC |
https://ClinicalTrials.gov/show/NCT02315755 |
Completed |
Pfizer |
2017-11-20 |
| NCT02302118 |
Esophagogastrectomy Versus Extended Gastrectomy in AEG II |
https://ClinicalTrials.gov/show/NCT02302118 |
Completed |
Universitätsklinikum Hamburg-Eppendorf |
2015-10-31 |
| NCT02296970 |
An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence |
https://ClinicalTrials.gov/show/NCT02296970 |
Completed |
University of Pittsburgh |
2016-06-30 |
| NCT02288910 |
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver |
https://ClinicalTrials.gov/show/NCT02288910 |
Active, not recruiting |
Rush University Medical Center |
2019-07-31 |
| NCT02282579 |
Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy |
https://ClinicalTrials.gov/show/NCT02282579 |
Completed |
Spanish Oncology Genito-Urinary Group |
2015-02-28 |
| NCT02279459 |
Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT02279459 |
Completed |
Ottawa Hospital Research Institute |
2018-10-01 |
| NCT02269995 |
Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02269995 |
Completed |
Eisai Inc. |
2015-05-14 |
| NCT02245100 |
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02245100 |
Recruiting |
Thomas Jefferson University |
2020-07-31 |
| NCT02247583 |
Investigating Patient Satisfaction With Oral Anti-Cancer Treatment |
https://ClinicalTrials.gov/show/NCT02247583 |
Completed |
KU Leuven |
2013-07-31 |
| NCT02228954 |
IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) |
https://ClinicalTrials.gov/show/NCT02228954 |
Active, not recruiting |
Radboud University |
2018-03-05 |
| NCT02228265 |
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide |
https://ClinicalTrials.gov/show/NCT02228265 |
Active, not recruiting |
OHSU Knight Cancer Institute |
2019-10-01 |
| NCT02199132 |
Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli |
https://ClinicalTrials.gov/show/NCT02199132 |
Completed |
Corporacion Parc Tauli |
2014-10-31 |
| NCT02187042 |
Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line |
https://ClinicalTrials.gov/show/NCT02187042 |
Completed |
Pfizer |
2018-07-25 |
| NCT02184416 |
Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting |
https://ClinicalTrials.gov/show/NCT02184416 |
Recruiting |
Pfizer |
2021-05-01 |
| NCT02185560 |
Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib |
https://ClinicalTrials.gov/show/NCT02185560 |
Active, not recruiting |
Bayer |
2020-02-27 |
| NCT04021056 |
Observational Study on Patients With Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT04021056 |
Recruiting |
Nanfang Hospital of Southern Medical University |
2019-08-31 |
| NCT02159339 |
DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma |
https://ClinicalTrials.gov/show/NCT02159339 |
Completed |
Beijing Cancer Hospital |
2015-06-30 |
| NCT02143492 |
Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC |
https://ClinicalTrials.gov/show/NCT02143492 |
Completed |
Argos Therapeutics |
2015-07-31 |
| NCT02139020 |
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients |
https://ClinicalTrials.gov/show/NCT02139020 |
Recruiting |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2023-01-31 |
| NCT02128334 |
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation |
https://ClinicalTrials.gov/show/NCT02128334 |
Completed |
Astellas Pharma Inc |
2016-03-31 |
| NCT02115477 |
Lymphedema After Primary Surgery for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02115477 |
Completed |
University Hospital, Linkoeping |
2018-12-17 |
| NCT02113865 |
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients |
https://ClinicalTrials.gov/show/NCT02113865 |
Completed |
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
2014-10-31 |
| NCT02100111 |
An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants |
https://ClinicalTrials.gov/show/NCT02100111 |
Completed |
Hoffmann-La Roche |
2011-12-31 |
| NCT02095912 |
Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients |
https://ClinicalTrials.gov/show/NCT02095912 |
Completed |
University of Zurich |
2015-11-30 |
| NCT02093104 |
TACE Study-Liver Embolization Perfusion (VGH Radiology LIU) |
https://ClinicalTrials.gov/show/NCT02093104 |
Completed |
University of British Columbia |
2016-04-30 |
| NCT01365208 |
New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT01365208 |
Completed |
Chinese University of Hong Kong |
2017-03-03 |
| NCT02063399 |
Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis |
https://ClinicalTrials.gov/show/NCT02063399 |
Active, not recruiting |
Chinese University of Hong Kong |
2016-08-31 |
| NCT02061956 |
A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02061956 |
Completed |
Sun Yat-sen University |
2011-12-31 |
| NCT01316679 |
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 |
https://ClinicalTrials.gov/show/NCT01316679 |
Completed |
Vanderbilt University Medical Center |
2013-01-31 |
| NCT01304173 |
Retrospective Chart Review of Valstar |
https://ClinicalTrials.gov/show/NCT01304173 |
Completed |
Endo Pharmaceuticals |
2011-09-30 |
| NCT01295489 |
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT01295489 |
Completed |
Gynecologic Oncology Group |
2018-01-31 |
| NCT01279408 |
Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC) |
https://ClinicalTrials.gov/show/NCT01279408 |
Active, not recruiting |
University Health Network, Toronto |
2028-11-30 |
| NCT02056041 |
Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02056041 |
Completed |
University of Milan |
2013-12-31 |
| NCT02016833 |
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity |
https://ClinicalTrials.gov/show/NCT02016833 |
Completed |
PX Biosolutions |
2014-06-30 |
| NCT02015026 |
Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma |
https://ClinicalTrials.gov/show/NCT02015026 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-10-16 |
| NCT01992861 |
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer |
https://ClinicalTrials.gov/show/NCT01992861 |
Recruiting |
University of Washington |
2021-09-30 |
| NCT01957852 |
FloSeal in CRS and HIPEC |
https://ClinicalTrials.gov/show/NCT01957852 |
Completed |
Maisonneuve-Rosemont Hospital |
2013-03-31 |
| NCT01958515 |
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation |
https://ClinicalTrials.gov/show/NCT01958515 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2017-02-15 |
| NCT01953640 |
Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy |
https://ClinicalTrials.gov/show/NCT01953640 |
Active, not recruiting |
Mayo Clinic |
2015-12-03 |
| NCT01942005 |
EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients |
https://ClinicalTrials.gov/show/NCT01942005 |
Completed |
University Hospital, Basel, Switzerland |
2014-05-31 |
| NCT01933945 |
Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib |
https://ClinicalTrials.gov/show/NCT01933945 |
Completed |
Bayer |
2017-07-22 |
| NCT01917214 |
A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival |
https://ClinicalTrials.gov/show/NCT01917214 |
Completed |
Pfizer |
2014-03-31 |
| NCT01908322 |
Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety |
https://ClinicalTrials.gov/show/NCT01908322 |
Completed |
Bayer |
2015-06-30 |
| NCT01904942 |
Study of Hepatocellular Carcinoma in Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT01904942 |
Completed |
Centre Hospitalier Universitaire Dijon |
2010-06-30 |
| NCT01872130 |
Reflectance Confocal Microscopy of Wounds During Moh’s Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins |
https://ClinicalTrials.gov/show/NCT01872130 |
Completed |
Memorial Sloan Kettering Cancer Center |
2020-04-28 |
| NCT01839630 |
Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China |
https://ClinicalTrials.gov/show/NCT01839630 |
Completed |
Bayer |
2016-08-06 |
| NCT01840280 |
A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer |
https://ClinicalTrials.gov/show/NCT01840280 |
Completed |
Onkovis GmbH |
2018-04-30 |
| NCT01836484 |
Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma |
https://ClinicalTrials.gov/show/NCT01836484 |
Completed |
Barts & The London NHS Trust |
2018-12-31 |
| NCT01783158 |
Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma |
https://ClinicalTrials.gov/show/NCT01783158 |
Completed |
University Hospital Ostrava |
2012-11-30 |
| NCT01777698 |
Body Composition Analysis in Patients Undergoing Chemoembolization |
https://ClinicalTrials.gov/show/NCT01777698 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2015-08-31 |
| NCT01759355 |
Hybrid PET/MR in the Therapy of Cervical Cancer |
https://ClinicalTrials.gov/show/NCT01759355 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-11-30 |
| NCT01728948 |
Sorafenib in Elderly mRCC |
https://ClinicalTrials.gov/show/NCT01728948 |
Completed |
Bayer |
2016-01-04 |
| NCT01668108 |
A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer |
https://ClinicalTrials.gov/show/NCT01668108 |
Completed |
Onkovis GmbH |
2018-05-31 |
| NCT01657695 |
Hepatocellular Carcinoma Growth and Molecular Aggressiveness |
https://ClinicalTrials.gov/show/NCT01657695 |
Completed |
University of Modena and Reggio Emilia |
2012-05-31 |
| NCT01649778 |
Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01649778 |
Completed |
Novartis |
2017-07-03 |
| NCT01617382 |
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed |
https://ClinicalTrials.gov/show/NCT01617382 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2025-01-31 |
| NCT01614002 |
A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer |
https://ClinicalTrials.gov/show/NCT01614002 |
Completed |
Onkovis GmbH |
2015-03-31 |
| NCT01606293 |
Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix |
https://ClinicalTrials.gov/show/NCT01606293 |
Recruiting |
M.D. Anderson Cancer Center |
2021-05-31 |
| NCT01585974 |
Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01585974 |
Completed |
Bayer |
2015-06-30 |
| NCT01545063 |
CAre of Patients With PArenteral Nutrition At Home |
https://ClinicalTrials.gov/show/NCT01545063 |
Completed |
KU Leuven |
2013-04-30 |
| NCT01540695 |
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology |
https://ClinicalTrials.gov/show/NCT01540695 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2013-01-31 |
| NCT01538498 |
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01538498 |
Completed |
National Cancer Center, Korea |
2012-11-30 |
| NCT01539681 |
Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy |
https://ClinicalTrials.gov/show/NCT01539681 |
Completed |
Bayer |
2014-01-31 |
| NCT01520779 |
Recurrence of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01520779 |
Completed |
Ain Shams University |
2012-11-30 |
| NCT01518829 |
Procalcitonin in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01518829 |
Completed |
Ain Shams University |
2012-12-31 |
| NCT01508364 |
Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01508364 |
Completed |
Bayer |
2013-12-31 |
| NCT01500954 |
Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01500954 |
Completed |
Ruhr University of Bochum |
2011-12-31 |
| NCT01498250 |
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01498250 |
Completed |
Ruhr University of Bochum |
2011-12-31 |
| NCT01487057 |
Lipid Metabolic Status in Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT01487057 |
Completed |
Prof. Dr. I. Chiricuta Institute of Oncology |
2012-02-29 |
| NCT01482520 |
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01482520 |
Completed |
Samsung Medical Center |
2013-09-30 |
| NCT01481805 |
Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT01481805 |
Completed |
Samsung Medical Center |
2014-01-13 |
| NCT01472419 |
Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01472419 |
Completed |
Samsung Medical Center |
2012-12-31 |
| NCT01473121 |
Hepatocellular Carcinoma Registry for Turkey (3K Trial) |
https://ClinicalTrials.gov/show/NCT01473121 |
Completed |
Bayer |
2017-06-30 |
| NCT01446666 |
Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients |
https://ClinicalTrials.gov/show/NCT01446666 |
Completed |
Asan Medical Center |
2014-12-31 |
| NCT01441661 |
Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01441661 |
Completed |
Cancer Foundation, China |
2012-06-30 |
| NCT01434355 |
DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings |
https://ClinicalTrials.gov/show/NCT01434355 |
Completed |
Children’s Oncology Group |
2016-08-04 |
| NCT01424878 |
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients |
https://ClinicalTrials.gov/show/NCT01424878 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01412671 |
Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program |
https://ClinicalTrials.gov/show/NCT01412671 |
Completed |
Bayer |
2011-09-21 |
| NCT01411436 |
Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan |
https://ClinicalTrials.gov/show/NCT01411436 |
Completed |
Bayer |
2014-03-31 |
| NCT01411423 |
Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan |
https://ClinicalTrials.gov/show/NCT01411423 |
Completed |
Bayer |
2012-03-16 |
| NCT01405183 |
Association Between Hepatitis C Infection and Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01405183 |
Completed |
Henry Ford Health System |
2013-08-31 |
| NCT01403480 |
Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions |
https://ClinicalTrials.gov/show/NCT01403480 |
Completed |
Rambam Health Care Campus |
2010-12-31 |
| NCT01395225 |
Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer |
https://ClinicalTrials.gov/show/NCT01395225 |
Completed |
University of British Columbia |
2013-04-30 |
| NCT01398306 |
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. |
https://ClinicalTrials.gov/show/NCT01398306 |
Completed |
University Medical Center Groningen |
2012-04-30 |
| NCT01385722 |
Molecular Analysis of Thoracic Malignancies |
https://ClinicalTrials.gov/show/NCT01385722 |
Enrolling by invitation |
Stanford University |
2031-06-30 |
| NCT01381614 |
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS) |
https://ClinicalTrials.gov/show/NCT01381614 |
Completed |
GlaxoSmithKline |
2011-12-31 |
| NCT01381601 |
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics) |
https://ClinicalTrials.gov/show/NCT01381601 |
Completed |
GlaxoSmithKline |
2011-10-31 |
| NCT01372787 |
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT01372787 |
Active, not recruiting |
Gynecologic Oncology Group |
2014-01-31 |
| NCT01370824 |
Clinical Diagnosis of Basal Cell Carcinoma Subtype |
https://ClinicalTrials.gov/show/NCT01370824 |
Completed |
Maastricht University Medical Center |
2013-02-28 |
| NCT01367457 |
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus |
https://ClinicalTrials.gov/show/NCT01367457 |
Completed |
Pfizer |
2015-04-30 |
| NCT01361061 |
AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver |
https://ClinicalTrials.gov/show/NCT01361061 |
Completed |
University Hospital Freiburg |
2015-11-30 |
| NCT01360255 |
AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) |
https://ClinicalTrials.gov/show/NCT01360255 |
Completed |
University Hospital Freiburg |
2015-11-30 |
| NCT01358097 |
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy |
https://ClinicalTrials.gov/show/NCT01358097 |
Completed |
Icahn School of Medicine at Mount Sinai |
2013-09-30 |
| NCT01349075 |
TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01349075 |
Recruiting |
Thomas Jefferson University |
2020-12-31 |
| NCT01339975 |
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01339975 |
Completed |
University Hospital, Bordeaux |
2014-05-31 |
| NCT01339962 |
Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2. |
https://ClinicalTrials.gov/show/NCT01339962 |
Completed |
Pfizer |
2012-04-30 |
| NCT01321892 |
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium |
https://ClinicalTrials.gov/show/NCT01321892 |
Completed |
Icahn School of Medicine at Mount Sinai |
2012-05-31 |
| NCT03233360 |
Hepatocellular Carcinoma Registry in Asia |
https://ClinicalTrials.gov/show/NCT03233360 |
Recruiting |
National Cancer Centre, Singapore |
2022-03-31 |
| NCT04416646 |
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04416646 |
Recruiting |
Istituto Oncologico Veneto IRCCS |
2020-06-27 |
| NCT04410302 |
Patient-Derived Xenografts to Reduce Cancer Health Disparities |
https://ClinicalTrials.gov/show/NCT04410302 |
Recruiting |
University of California, Davis |
2023-06-30 |
| NCT04375150 |
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC |
https://ClinicalTrials.gov/show/NCT04375150 |
Active, not recruiting |
Pfizer |
2021-03-02 |
| NCT04367805 |
COVID-19 Infection in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04367805 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2020-10-31 |
| NCT04350047 |
Renal Cell Carcinoma and Stage IV Inferior Vena Cava Thrombus: Resection Without Thoracotomy |
https://ClinicalTrials.gov/show/NCT04350047 |
Completed |
Attikon Hospital |
2020-03-31 |
| NCT04348838 |
Prospective Cohort of Patients With Hepatocellular Carcinoma in France |
https://ClinicalTrials.gov/show/NCT04348838 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2027-09-30 |
| NCT04341337 |
Link of Interest and Training Model |
https://ClinicalTrials.gov/show/NCT04341337 |
Completed |
Centre de l’arthrose, Paris |
2020-04-06 |
| NCT04314245 |
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma |
https://ClinicalTrials.gov/show/NCT04314245 |
Recruiting |
AnchorDx Medical Co., Ltd. |
2020-08-31 |
| NCT04307654 |
Lactate and Complications in Cytoreduction Surgery for Peritoneal Carcinomatosis |
https://ClinicalTrials.gov/show/NCT04307654 |
Completed |
Hospital General Universitario de Castellón |
2014-06-30 |
| NCT04309617 |
Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy |
https://ClinicalTrials.gov/show/NCT04309617 |
Recruiting |
Pfizer |
2020-04-15 |
| NCT04303286 |
The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04303286 |
Recruiting |
Tongji Hospital |
2020-05-31 |
| NCT04299919 |
The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment |
https://ClinicalTrials.gov/show/NCT04299919 |
Active, not recruiting |
The First Affiliated Hospital of Dalian Medical University |
2023-06-30 |
| NCT04296058 |
The Mechanism of Sox4 Transcription in Regulation of Angiogenesis in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04296058 |
Completed |
Chang Gung Memorial Hospital |
2019-03-31 |
| NCT04264754 |
Characterization of Methylation Patterns in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04264754 |
Recruiting |
Nucleix Ltd. |
2024-12-31 |
| NCT04257045 |
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives |
https://ClinicalTrials.gov/show/NCT04257045 |
Recruiting |
M.D. Anderson Cancer Center |
2022-12-31 |
| NCT04252560 |
The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer. |
https://ClinicalTrials.gov/show/NCT04252560 |
Recruiting |
Uppsala University Hospital |
2021-01-31 |
| NCT04260074 |
Epigenetic Changes in Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT04260074 |
Recruiting |
Aalborg University Hospital |
2020-07-31 |
| NCT04239781 |
A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04239781 |
Recruiting |
Shanghai Zhongshan Hospital |
2020-06-30 |
| NCT04228237 |
LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS) |
https://ClinicalTrials.gov/show/NCT04228237 |
Recruiting |
Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s. |
2025-05-31 |
| NCT04224389 |
IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT04224389 |
Recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2023-06-30 |
| NCT04222374 |
Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC) |
https://ClinicalTrials.gov/show/NCT04222374 |
Recruiting |
University Hospital, Bordeaux |
2020-04-30 |
| NCT04221347 |
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC |
https://ClinicalTrials.gov/show/NCT04221347 |
Recruiting |
Military University Hospital, Prague |
2020-12-31 |
| NCT04213664 |
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma. |
https://ClinicalTrials.gov/show/NCT04213664 |
Recruiting |
Corporacion Parc Tauli |
2020-01-02 |
| NCT04209491 |
Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway |
https://ClinicalTrials.gov/show/NCT04209491 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-02-01 |
| NCT04204811 |
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy |
https://ClinicalTrials.gov/show/NCT04204811 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2020-12-16 |
| NCT04201002 |
Surgery Plus Intraoperative Radiotherapy as Treatment for Squamous Cell Carcinoma Over Pilonidal Disease. |
https://ClinicalTrials.gov/show/NCT04201002 |
Completed |
Hospital Provincial de Castellon |
2019-10-11 |
| NCT04199832 |
To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy |
https://ClinicalTrials.gov/show/NCT04199832 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2020-12-31 |
| NCT04189809 |
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations |
https://ClinicalTrials.gov/show/NCT04189809 |
Active, not recruiting |
University Hospital, Montpellier |
2020-03-01 |
| NCT04183218 |
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes in Non-metastatic, Non-recurrent Lung and Esophageal Cancer Patients |
https://ClinicalTrials.gov/show/NCT04183218 |
Recruiting |
Mayo Clinic |
2021-09-23 |
| NCT04177316 |
Hypermethylation of VTRNA2-1 Promoter in HCC Outcome |
https://ClinicalTrials.gov/show/NCT04177316 |
Completed |
Chang Gung Memorial Hospital |
2019-11-15 |
| NCT04175262 |
Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments |
https://ClinicalTrials.gov/show/NCT04175262 |
Completed |
Pfizer |
2020-03-09 |
| NCT04172194 |
Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas |
https://ClinicalTrials.gov/show/NCT04172194 |
Completed |
Centre Hospitalier Universitaire de Nice |
2014-12-31 |
| NCT04161911 |
A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy |
https://ClinicalTrials.gov/show/NCT04161911 |
Completed |
Bristol-Myers Squibb |
2018-11-15 |
| NCT04161287 |
Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE |
https://ClinicalTrials.gov/show/NCT04161287 |
Recruiting |
Beijing 302 Hospital |
2022-11-11 |
| NCT04160897 |
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04160897 |
Enrolling by invitation |
Ruijin Hospital |
2020-10-31 |
| NCT04152356 |
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04152356 |
Recruiting |
Guangxi Medical University |
2020-08-01 |
| NCT04151940 |
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04151940 |
Recruiting |
University of Washington |
2021-06-01 |
| NCT04147143 |
CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study |
https://ClinicalTrials.gov/show/NCT04147143 |
Recruiting |
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
2020-03-08 |
| NCT04115189 |
A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA) |
https://ClinicalTrials.gov/show/NCT04115189 |
Recruiting |
Pfizer |
2020-04-30 |
| NCT04108936 |
Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses |
https://ClinicalTrials.gov/show/NCT04108936 |
Recruiting |
University of Regensburg |
2020-06-30 |
| NCT04106167 |
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy |
https://ClinicalTrials.gov/show/NCT04106167 |
Recruiting |
Fate Therapeutics |
2034-02-28 |
| NCT04094545 |
Intestinal Flora Sequencing for Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT04094545 |
Completed |
The Third Xiangya Hospital of Central South University |
2018-12-31 |
| NCT04099290 |
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04099290 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-09-30 |
| NCT04076787 |
Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib |
https://ClinicalTrials.gov/show/NCT04076787 |
Completed |
Pfizer |
2018-09-02 |
| NCT04076631 |
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04076631 |
Recruiting |
Tongji Hospital |
2020-09-30 |
| NCT04069299 |
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract |
https://ClinicalTrials.gov/show/NCT04069299 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-12-01 |
| NCT04066504 |
Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04066504 |
Recruiting |
Sun Pharmaceutical Industries Limited |
2024-11-01 |
| NCT04053855 |
Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04053855 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2021-09-30 |
| NCT04050761 |
A Study of Nivolumab in Patients With Head and Neck Cancer. |
https://ClinicalTrials.gov/show/NCT04050761 |
Recruiting |
Bristol-Myers Squibb |
2024-06-26 |
| NCT04033991 |
Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib. |
https://ClinicalTrials.gov/show/NCT04033991 |
Active, not recruiting |
Pfizer |
2020-05-31 |
| NCT04043975 |
A Prospective Observational Study of Renal Cell Cancer Patients Treated With Nivolumab Plus Ipilimumab in the Real World Setting in Japan |
https://ClinicalTrials.gov/show/NCT04043975 |
Recruiting |
Bristol-Myers Squibb |
2022-08-01 |
| NCT04027543 |
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study） |
https://ClinicalTrials.gov/show/NCT04027543 |
Completed |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2019-12-01 |
| NCT04021069 |
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer |
https://ClinicalTrials.gov/show/NCT04021069 |
Active, not recruiting |
Sunnybrook Health Sciences Centre |
2019-12-30 |
| NCT04008082 |
A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04008082 |
Recruiting |
Eisai Inc. |
2023-05-31 |
| NCT04005183 |
Renal Cell Carcinoma Microenvironment Discovery Project |
https://ClinicalTrials.gov/show/NCT04005183 |
Recruiting |
University Health Network, Toronto |
2030-05-01 |
| NCT04006405 |
AURORAX-087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC |
https://ClinicalTrials.gov/show/NCT04006405 |
Recruiting |
Elypta |
2022-02-28 |
| NCT04003025 |
Body Composition and Prognosis in Head and Neck Squamous Cell Carcinoma (HNSCC) |
https://ClinicalTrials.gov/show/NCT04003025 |
Recruiting |
Instituto do Cancer do Estado de São Paulo |
2020-07-31 |
| NCT03998371 |
Application of UCAD for Diagnosing Urothelial Carcinoma. |
https://ClinicalTrials.gov/show/NCT03998371 |
Recruiting |
Changhai Hospital |
2020-05-05 |
| NCT03989297 |
PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03989297 |
Recruiting |
Kiang Wu Hospital |
2019-12-01 |
| NCT03987555 |
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients |
https://ClinicalTrials.gov/show/NCT03987555 |
Recruiting |
Wake Forest University Health Sciences |
2021-03-31 |
| NCT03981224 |
The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT03981224 |
Completed |
Taichung Veterans General Hospital |
2013-05-01 |
| NCT03958669 |
Fingerprint Characterization of Sorafenib Treated HCC |
https://ClinicalTrials.gov/show/NCT03958669 |
Recruiting |
University Hospital Tuebingen |
2021-06-30 |
| NCT03953443 |
Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC |
https://ClinicalTrials.gov/show/NCT03953443 |
Enrolling by invitation |
New Mexico Cancer Care Alliance |
2025-12-31 |
| NCT03945786 |
Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT03945786 |
Enrolling by invitation |
Xuanwu Hospital, Beijing |
2020-12-31 |
| NCT03938012 |
Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03938012 |
Recruiting |
National University Hospital, Singapore |
2021-10-31 |
| NCT03928964 |
MEtatastic Renal Carcinoma LINes |
https://ClinicalTrials.gov/show/NCT03928964 |
Active, not recruiting |
Centre Hospitalier Universitaire de Besancon |
2018-10-03 |
| NCT03931304 |
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) |
https://ClinicalTrials.gov/show/NCT03931304 |
Completed |
Hospices Civils de Lyon |
2018-07-31 |
| NCT03916458 |
REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA |
https://ClinicalTrials.gov/show/NCT03916458 |
Recruiting |
Pfizer |
2020-09-30 |
| NCT03904667 |
Application of Watson for Oncology in Hepatocellular Carcinoma Surgery |
https://ClinicalTrials.gov/show/NCT03904667 |
Active, not recruiting |
Zhujiang Hospital |
2021-12-31 |
| NCT03902535 |
Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers |
https://ClinicalTrials.gov/show/NCT03902535 |
Recruiting |
City of Hope Medical Center |
2020-12-10 |
| NCT03894917 |
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03894917 |
Recruiting |
The University of Texas Health Science Center at San Antonio |
2020-04-30 |
| NCT03881501 |
Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03881501 |
Recruiting |
Huazhong University of Science and Technology |
2020-03-31 |
| NCT03880721 |
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation |
https://ClinicalTrials.gov/show/NCT03880721 |
Recruiting |
Chinese PLA General Hospital |
2020-08-31 |
| NCT03878550 |
Case-Control Study of the Glycotestâ„¢ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03878550 |
Recruiting |
Glycotest, Inc. |
2020-12-31 |
| NCT03855020 |
Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT03855020 |
Recruiting |
Sun Yat-sen University |
2022-05-10 |
| NCT03852238 |
Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study) |
https://ClinicalTrials.gov/show/NCT03852238 |
Completed |
University Hospital, Bordeaux |
2013-11-14 |
| NCT03830996 |
Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03830996 |
Recruiting |
The University of Hong Kong |
2020-12-31 |
| NCT03810274 |
3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03810274 |
Completed |
Xinqiao Hospital of Chongqing |
2018-12-31 |
| NCT03805971 |
Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis. |
https://ClinicalTrials.gov/show/NCT03805971 |
Completed |
University of Liege |
2019-10-15 |
| NCT03804593 |
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT03804593 |
Completed |
Epigenomics, Inc |
2019-10-01 |
| NCT03804255 |
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting |
https://ClinicalTrials.gov/show/NCT03804255 |
Recruiting |
Eastern Cooperative Oncology Group |
2020-02-01 |
| NCT03798132 |
Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic. |
https://ClinicalTrials.gov/show/NCT03798132 |
Recruiting |
South Egypt Cancer Institute |
2019-06-11 |
| NCT03794115 |
Immune Repertoire of Ovarian HGSC |
https://ClinicalTrials.gov/show/NCT03794115 |
Recruiting |
Peking Union Medical College Hospital |
2021-01-01 |
| NCT03776123 |
Post Marketing Surveillance to Observe Safety and Effectiveness of CABOMETYXâ„¢ in Korea. |
https://ClinicalTrials.gov/show/NCT03776123 |
Recruiting |
Ipsen |
2022-02-28 |
| NCT03775863 |
AFP Model and Liver Transplantation. |
https://ClinicalTrials.gov/show/NCT03775863 |
Completed |
Austral University, Argentina |
2018-12-12 |
| NCT03774862 |
Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study |
https://ClinicalTrials.gov/show/NCT03774862 |
Completed |
V.K.V. American Hospital, Istanbul |
2017-12-31 |
| NCT03767764 |
Yliver as a Test to Early Diagnose HCC |
https://ClinicalTrials.gov/show/NCT03767764 |
Active, not recruiting |
Corporacion Parc Tauli |
2020-04-01 |
| NCT03766672 |
Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique |
https://ClinicalTrials.gov/show/NCT03766672 |
Recruiting |
University Hospital Center of Martinique |
2021-01-07 |
| NCT03759730 |
Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03759730 |
Completed |
University Health Network, Toronto |
2018-11-28 |
| NCT03756051 |
Harms of Hepatocellular Carcinoma Surveillance |
https://ClinicalTrials.gov/show/NCT03756051 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2022-04-30 |
| NCT03748901 |
PD-L1 Expression in Japanese Renal Cell Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT03748901 |
Active, not recruiting |
Chugai Pharmaceutical |
2019-12-31 |
| NCT03744585 |
Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts. |
https://ClinicalTrials.gov/show/NCT03744585 |
Completed |
Ipsen |
2019-06-07 |
| NCT03737695 |
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer |
https://ClinicalTrials.gov/show/NCT03737695 |
Recruiting |
Mayo Clinic |
2020-11-05 |
| NCT03734614 |
Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03734614 |
Recruiting |
RenJi Hospital |
2024-10-31 |
| NCT03735511 |
A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma |
https://ClinicalTrials.gov/show/NCT03735511 |
Active, not recruiting |
Henan Cancer Hospital |
2020-08-31 |
| NCT03734068 |
Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC |
https://ClinicalTrials.gov/show/NCT03734068 |
Recruiting |
International Group of Endovascular Oncology |
2021-06-30 |
| NCT03728842 |
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03728842 |
Recruiting |
Indiana University |
2021-03-01 |
| NCT03727594 |
Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03727594 |
Recruiting |
University Hospital of Ferrara |
2020-01-31 |
| NCT03712566 |
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy |
https://ClinicalTrials.gov/show/NCT03712566 |
Active, not recruiting |
University Health Network, Toronto |
2022-10-31 |
| NCT03707080 |
Direct Acting Antiviral-Post Authorization Safety Study |
https://ClinicalTrials.gov/show/NCT03707080 |
Active, not recruiting |
Target PharmaSolutions, Inc. |
2020-12-31 |
| NCT03699579 |
Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC |
https://ClinicalTrials.gov/show/NCT03699579 |
Completed |
Ipsen |
2019-06-23 |
| NCT03702998 |
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population |
https://ClinicalTrials.gov/show/NCT03702998 |
Recruiting |
Chinese University of Hong Kong |
2020-07-31 |
| NCT03696407 |
A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK |
https://ClinicalTrials.gov/show/NCT03696407 |
Completed |
Ipsen |
2019-08-01 |
| NCT03670992 |
Surgical Treatment of Pancreatic RCC Metastases |
https://ClinicalTrials.gov/show/NCT03670992 |
Completed |
Azienda Policlinico Umberto I |
2017-01-10 |
| NCT03663946 |
A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread |
https://ClinicalTrials.gov/show/NCT03663946 |
Recruiting |
Bristol-Myers Squibb |
2021-12-31 |
| NCT03663114 |
A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03663114 |
Active, not recruiting |
Eisai Inc. |
2021-05-31 |
| NCT03647878 |
Study of Cabozantinib in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment. |
https://ClinicalTrials.gov/show/NCT03647878 |
Recruiting |
Ipsen |
2022-08-30 |
| NCT03647527 |
Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy |
https://ClinicalTrials.gov/show/NCT03647527 |
Recruiting |
Zhejiang Cancer Hospital |
2018-11-30 |
| NCT03630068 |
Computer-assisted Tumor Ablation for Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT03630068 |
Completed |
University Hospital Inselspital, Berne |
2017-12-31 |
| NCT03628651 |
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03628651 |
Completed |
Exact Sciences Corporation |
2020-03-11 |
| NCT03612726 |
The Overall Survival of Patients With Unresectable HCC in Real-life |
https://ClinicalTrials.gov/show/NCT03612726 |
Recruiting |
Humanity & Health Medical Group Limited |
2023-07-31 |
| NCT03604601 |
Analysis of the Curative Effect of Salvage Surgery on Recurrent Laryngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03604601 |
Completed |
First Affiliated Hospital, Sun Yat-Sen University |
2018-06-01 |
| NCT03601390 |
Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC |
https://ClinicalTrials.gov/show/NCT03601390 |
Recruiting |
Sun Yat-sen University |
2019-12-01 |
| NCT03593681 |
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy |
https://ClinicalTrials.gov/show/NCT03593681 |
Completed |
Boston Scientific Corporation |
2020-02-14 |
| NCT03588442 |
Prospective Surveillance for Very Early Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03588442 |
Recruiting |
Eastern Hepatobiliary Surgery Hospital |
2022-07-15 |
| NCT03588403 |
TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT03588403 |
Recruiting |
Zhejiang Cancer Hospital |
2022-07-31 |
| NCT03583528 |
DOTATOC PET/CT for Imaging NET Patients |
https://ClinicalTrials.gov/show/NCT03583528 |
Recruiting |
British Columbia Cancer Agency |
2023-12-31 |
| NCT03581435 |
A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT03581435 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2018-12-30 |
| NCT03563352 |
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03563352 |
Recruiting |
University of Southern California |
2020-08-30 |
| NCT03554967 |
Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03554967 |
Completed |
Cairo University |
2019-06-03 |
| NCT03534843 |
A Comparison Between Child-Pugh and Albumin-Bilirubin Scores |
https://ClinicalTrials.gov/show/NCT03534843 |
Completed |
Huazhong University of Science and Technology |
2015-08-01 |
| NCT03529604 |
Salivary Ap4A, SCCA, TROP2 in Oral Cancer Patients |
https://ClinicalTrials.gov/show/NCT03529604 |
Active, not recruiting |
University of Zagreb |
2020-04-01 |
| NCT03519542 |
Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03519542 |
Completed |
Spanish Oncology Genito-Urinary Group |
2016-12-31 |
| NCT03516890 |
Management of Spontaneous Ruptured Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03516890 |
Completed |
Huazhong University of Science and Technology |
2015-06-01 |
| NCT03509415 |
Reflectance Confocal Microscopy to Diagnose BCC |
https://ClinicalTrials.gov/show/NCT03509415 |
Active, not recruiting |
Skin Care Network Ltd. |
2019-02-28 |
| NCT03490461 |
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT03490461 |
Completed |
Yonsei University |
2018-03-01 |
| NCT03483922 |
HCC Screening Using DNA Methylation Changes in ctDNA |
https://ClinicalTrials.gov/show/NCT03483922 |
Recruiting |
HKGepitherapeutics |
2020-06-01 |
| NCT03476421 |
R1vascular Hepatectomy for HCC Patients |
https://ClinicalTrials.gov/show/NCT03476421 |
Completed |
Humanitas Clinical and Research Center |
2015-12-31 |
| NCT03471897 |
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03471897 |
Completed |
Chalmers University of Technology |
2017-10-25 |
| NCT03469596 |
Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor? |
https://ClinicalTrials.gov/show/NCT03469596 |
Completed |
Groupe Hospitalier Paris Saint Joseph |
2017-05-01 |
| NCT03455452 |
An Observational Study of Nivolumab in Participants With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT03455452 |
Recruiting |
Bristol-Myers Squibb |
2022-01-18 |
| NCT03430635 |
Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03430635 |
Completed |
Humanitas Clinical and Research Center |
2015-12-31 |
| NCT03419572 |
Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03419572 |
Recruiting |
Ipsen |
2021-01-05 |
| NCT03411954 |
Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT03411954 |
Recruiting |
Zhejiang Cancer Hospital |
2021-02-28 |
| NCT01268878 |
Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol |
https://ClinicalTrials.gov/show/NCT01268878 |
Completed |
Groupe Oncologie Radiotherapie Tete et Cou |
2011-11-30 |
| NCT01237132 |
East-West Hepatocellular Carcinoma Study Group |
https://ClinicalTrials.gov/show/NCT01237132 |
Completed |
University of Milan |
NA |
| NCT01227213 |
The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01227213 |
Completed |
Radboud University |
2013-11-30 |
| NCT01212562 |
Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery |
https://ClinicalTrials.gov/show/NCT01212562 |
Completed |
University of Ioannina |
2010-04-30 |
| NCT01210313 |
Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma |
https://ClinicalTrials.gov/show/NCT01210313 |
Completed |
Austrian Breast & Colorectal Cancer Study Group |
2013-04-30 |
| NCT01179360 |
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) |
https://ClinicalTrials.gov/show/NCT01179360 |
Completed |
University Hospital, Antwerp |
2015-12-31 |
| NCT01173445 |
Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01173445 |
Completed |
University of Kansas Medical Center |
2011-05-31 |
| NCT01151007 |
KRAS Mutation and Incidence of the Colorectal Carcinoma in Martinique Between 2007 and 2009 |
https://ClinicalTrials.gov/show/NCT01151007 |
Completed |
University Hospital Center of Martinique |
2011-10-31 |
| NCT01135849 |
B-Receptor Signaling in Cardiomyopathy |
https://ClinicalTrials.gov/show/NCT01135849 |
Completed |
Stanford University |
2010-10-31 |
| NCT01135823 |
Symptom Assessment With Patient Surveys |
https://ClinicalTrials.gov/show/NCT01135823 |
Completed |
Stanford University |
2008-06-30 |
| NCT01103544 |
JAVLOR® Online Non-Interventional Trial |
https://ClinicalTrials.gov/show/NCT01103544 |
Completed |
Pierre Fabre Pharma GmbH |
2011-09-30 |
| NCT01098630 |
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer |
https://ClinicalTrials.gov/show/NCT01098630 |
Completed |
Gynecologic Oncology Group |
2012-05-31 |
| NCT01080521 |
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT01080521 |
Completed |
Gynecologic Oncology Group |
2012-01-31 |
| NCT01080066 |
A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN) |
https://ClinicalTrials.gov/show/NCT01080066 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-12-31 |
| NCT01052740 |
X-Ray Mammography Standard of Care Protocol |
https://ClinicalTrials.gov/show/NCT01052740 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT01050504 |
Recruiting |
University of Washington |
2021-09-01 |
| NCT01034865 |
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT01034865 |
Completed |
Stanford University |
2009-06-30 |
| NCT01028638 |
Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01028638 |
Completed |
University Medical Center Groningen |
2015-01-31 |
| NCT01026337 |
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT01026337 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2015-12-31 |
| NCT01012011 |
Regulatory Post Marketing Surveillance Study on Nexavar® |
https://ClinicalTrials.gov/show/NCT01012011 |
Completed |
Bayer |
2015-01-31 |
| NCT00997633 |
Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy |
https://ClinicalTrials.gov/show/NCT00997633 |
Completed |
Uppsala University |
2004-08-31 |
| NCT00952874 |
Molecular Biology of Anal Cancer in HIV-Positive Patients |
https://ClinicalTrials.gov/show/NCT00952874 |
Completed |
University Hospital, Geneva |
2010-01-31 |
| NCT00930319 |
Effectiveness and Safety of Firmagon® |
https://ClinicalTrials.gov/show/NCT00930319 |
Completed |
Ferring Pharmaceuticals |
2013-12-31 |
| NCT00927043 |
Study Evaluating Renal Cell Carcinoma Risk Factors |
https://ClinicalTrials.gov/show/NCT00927043 |
Completed |
Pfizer |
2011-09-30 |
| NCT00918775 |
Follow-up After Metastasectomy in Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00918775 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-12-20 |
| NCT00911196 |
Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00911196 |
Completed |
GlaxoSmithKline |
2009-03-31 |
| NCT00897442 |
Collecting Tumor Samples From Patients With Gynecological Tumors |
https://ClinicalTrials.gov/show/NCT00897442 |
Completed |
Gynecologic Oncology Group |
2016-01-31 |
| NCT00901173 |
A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya |
https://ClinicalTrials.gov/show/NCT00901173 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-04-20 |
| NCT00898755 |
Collecting and Storing Tissue From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898755 |
Completed |
Children’s Oncology Group |
2008-07-17 |
| NCT00895674 |
Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar |
https://ClinicalTrials.gov/show/NCT00895674 |
Completed |
Bayer |
2010-08-31 |
| NCT00890903 |
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) |
https://ClinicalTrials.gov/show/NCT00890903 |
Completed |
Pierre Fabre Pharma GmbH |
2012-04-30 |
| NCT00883454 |
Estimation of Functional Liver Reserve Using Cholinesterases |
https://ClinicalTrials.gov/show/NCT00883454 |
Completed |
University of Milan |
NA |
| NCT00882791 |
Basal Cell Carcinoma Recurrence After Mohs Surgery |
https://ClinicalTrials.gov/show/NCT00882791 |
Completed |
Northwestern University |
2009-05-31 |
| NCT00880503 |
Collection of Tissue Samples for Study of Multidrug Resistance |
https://ClinicalTrials.gov/show/NCT00880503 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00858000 |
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00858000 |
Completed |
GlaxoSmithKline |
2009-12-31 |
| NCT03788746 |
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma |
https://ClinicalTrials.gov/show/NCT03788746 |
Recruiting |
AstraZeneca |
2020-12-09 |
| NCT03210935 |
French National Database of Rare Dermatological Cancers |
https://ClinicalTrials.gov/show/NCT03210935 |
Recruiting |
University Hospital, Lille |
2025-12-31 |
| NCT02156700 |
Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors |
https://ClinicalTrials.gov/show/NCT02156700 |
Completed |
University Hospital Dubrava |
2015-12-31 |
| NCT00831857 |
VEGF Imaging in Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00831857 |
Completed |
University Medical Center Groningen |
2011-09-30 |
| NCT00829335 |
Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach |
https://ClinicalTrials.gov/show/NCT00829335 |
Completed |
University of Milan |
2009-01-31 |
| NCT04291755 |
Development and Analysis of a Stool Bank for Cancer Patients |
https://ClinicalTrials.gov/show/NCT04291755 |
Recruiting |
Persephone Biosciences |
2020-12-31 |
| NCT04412161 |
Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP |
https://ClinicalTrials.gov/show/NCT04412161 |
Completed |
Inonu University |
2019-01-01 |
| NCT03100708 |
Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy) |
https://ClinicalTrials.gov/show/NCT03100708 |
Recruiting |
University of Leipzig |
2021-04-30 |
| NCT03071458 |
Mutational Landscape in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03071458 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2015-05-31 |
| NCT02834546 |
Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02834546 |
Completed |
University Hospital, Bordeaux |
2019-03-15 |
| NCT01942200 |
A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer |
https://ClinicalTrials.gov/show/NCT01942200 |
Completed |
Onkovis GmbH |
2018-07-25 |
| NCT01557127 |
Nexavar Dosing in Renal Cancer Patients in “Real-life” Setting |
https://ClinicalTrials.gov/show/NCT01557127 |
Completed |
Bayer |
2014-05-16 |
| NCT00804128 |
Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS) |
https://ClinicalTrials.gov/show/NCT00804128 |
Recruiting |
University of California, San Francisco |
2024-12-31 |
| NCT00876382 |
Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00876382 |
Completed |
SCRI Development Innovations, LLC |
2011-02-28 |
| NCT00875381 |
Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin |
https://ClinicalTrials.gov/show/NCT00875381 |
Completed |
Mayo Clinic |
2007-12-31 |
| NCT00873210 |
Study In Patients With Kidney Cancer Treated With Sutent |
https://ClinicalTrials.gov/show/NCT00873210 |
Completed |
Pfizer |
2011-11-30 |
| NCT00842790 |
Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging |
https://ClinicalTrials.gov/show/NCT00842790 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-07-31 |
| NCT03896958 |
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) |
https://ClinicalTrials.gov/show/NCT03896958 |
Recruiting |
SpeciCare |
2021-03-12 |
| NCT00834028 |
Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization |
https://ClinicalTrials.gov/show/NCT00834028 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2008-12-31 |
| NCT04415567 |
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT04415567 |
Completed |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2020-03-31 |
| NCT04411290 |
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases |
https://ClinicalTrials.gov/show/NCT04411290 |
Enrolling by invitation |
Umraniye Education and Research Hospital |
2021-06-01 |
| NCT03414827 |
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03414827 |
Recruiting |
Zealand University Hospital |
2020-12-01 |
| NCT02476669 |
Serial Plasma EBV DNA for Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT02476669 |
Recruiting |
The University of Hong Kong |
2020-12-31 |
| NCT00812175 |
Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib |
https://ClinicalTrials.gov/show/NCT00812175 |
Completed |
Bayer |
2012-04-30 |
| NCT01982097 |
Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01982097 |
Completed |
Bayer |
2017-01-31 |
| NCT01976468 |
Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The “SCOPE-ITSCC Metastases Study” |
https://ClinicalTrials.gov/show/NCT01976468 |
Active, not recruiting |
University of Zurich |
2023-01-31 |
| NCT04163627 |
Changing Trends in HCC Procedures |
https://ClinicalTrials.gov/show/NCT04163627 |
Recruiting |
University Hospital, Montpellier |
2021-03-01 |
| NCT04430725 |
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study |
https://ClinicalTrials.gov/show/NCT04430725 |
Recruiting |
M.D. Anderson Cancer Center |
2023-01-01 |
| NCT03267641 |
Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03267641 |
Recruiting |
National Cancer Centre, Singapore |
2021-05-31 |
| NCT03203837 |
Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® |
https://ClinicalTrials.gov/show/NCT03203837 |
Recruiting |
Northwestern University |
2020-05-31 |
| NCT03178409 |
Combined HCC-MFCCC |
https://ClinicalTrials.gov/show/NCT03178409 |
Completed |
University of Milan |
2014-12-31 |
| NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
https://ClinicalTrials.gov/show/NCT03050268 |
Recruiting |
St. Jude Children’s Research Hospital |
2037-03-31 |
| NCT02773667 |
Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine |
https://ClinicalTrials.gov/show/NCT02773667 |
Recruiting |
Jena University Hospital |
2020-12-31 |
| NCT02549638 |
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02549638 |
Recruiting |
Mayo Clinic |
2020-08-31 |
| NCT02558205 |
Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry |
https://ClinicalTrials.gov/show/NCT02558205 |
Recruiting |
Rush University Medical Center |
2020-07-31 |
| NCT02371967 |
A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT02371967 |
Active, not recruiting |
Hoffmann-La Roche |
2020-08-29 |
| NCT04451603 |
LiverMultiScan Analysis of MRI Scans in HCC |
https://ClinicalTrials.gov/show/NCT04451603 |
Recruiting |
National Cancer Centre, Singapore |
2021-12-31 |
| NCT01650987 |
Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function |
https://ClinicalTrials.gov/show/NCT01650987 |
Completed |
Centre Oscar Lambret |
2015-05-31 |
| NCT01490203 |
Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01490203 |
Completed |
Seoul National University Hospital |
2014-02-28 |
| NCT04432909 |
A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up |
https://ClinicalTrials.gov/show/NCT04432909 |
Recruiting |
Changhai Hospital |
2022-01-30 |
| NCT01328691 |
Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus |
https://ClinicalTrials.gov/show/NCT01328691 |
Completed |
Seoul National University Hospital |
2011-03-31 |
| NCT03973723 |
Plasma EBV DNA Monitoring in Post-treatment NPC Patients |
https://ClinicalTrials.gov/show/NCT03973723 |
Completed |
Taichung Veterans General Hospital |
2013-12-31 |
| NCT00827723 |
Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma |
https://ClinicalTrials.gov/show/NCT00827723 |
Completed |
University of Lausanne Hospitals |
2018-02-28 |
| NCT01014065 |
A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) |
https://ClinicalTrials.gov/show/NCT01014065 |
Completed |
AHS Cancer Control Alberta |
2012-11-30 |
| NCT00792350 |
INSIGHT - Post Marketing Surveillance |
https://ClinicalTrials.gov/show/NCT00792350 |
Completed |
Bayer |
2013-10-31 |
| NCT00793169 |
Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery |
https://ClinicalTrials.gov/show/NCT00793169 |
Completed |
Northwestern University |
2008-07-31 |
| NCT00771147 |
A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ® |
https://ClinicalTrials.gov/show/NCT00771147 |
Completed |
Bayer |
NA |
| NCT00764140 |
Tumor Growth Factors in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00764140 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2010-04-30 |
| NCT00759382 |
Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study. |
https://ClinicalTrials.gov/show/NCT00759382 |
Active, not recruiting |
European Lung Cancer Working Party |
2021-01-31 |
| NCT00743054 |
microRNA Expression in Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00743054 |
Completed |
Sun Yat-sen University |
2009-08-31 |
| NCT00718367 |
Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens |
https://ClinicalTrials.gov/show/NCT00718367 |
Completed |
National University Hospital, Singapore |
NA |
| NCT00717743 |
T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY) |
https://ClinicalTrials.gov/show/NCT00717743 |
Completed |
National University Hospital, Singapore |
NA |
| NCT00700258 |
Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] |
https://ClinicalTrials.gov/show/NCT00700258 |
Recruiting |
Pfizer |
2023-12-01 |
| NCT00684645 |
Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT® |
https://ClinicalTrials.gov/show/NCT00684645 |
Completed |
Pfizer |
2011-04-30 |
| NCT00662662 |
Sexual Behavior in Head and Neck Cancer Patients |
https://ClinicalTrials.gov/show/NCT00662662 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2022-05-31 |
| NCT00630240 |
Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization |
https://ClinicalTrials.gov/show/NCT00630240 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2009-02-28 |
| NCT00629421 |
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study |
https://ClinicalTrials.gov/show/NCT00629421 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2016-12-31 |
| NCT00620139 |
Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00620139 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-10-31 |
| NCT00605150 |
HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC |
https://ClinicalTrials.gov/show/NCT00605150 |
Completed |
Atrium Health |
2012-07-31 |
| NCT00601185 |
Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. |
https://ClinicalTrials.gov/show/NCT00601185 |
Completed |
Memorial Sloan Kettering Cancer Center |
2018-02-23 |
| NCT00581750 |
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ |
https://ClinicalTrials.gov/show/NCT00581750 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-10-31 |
| NCT00574392 |
Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo |
https://ClinicalTrials.gov/show/NCT00574392 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-09-30 |
| NCT00568139 |
Evaluation of Side Effects of Mitotane |
https://ClinicalTrials.gov/show/NCT00568139 |
Recruiting |
University of Wuerzburg |
2020-12-31 |
| NCT00540059 |
Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial |
https://ClinicalTrials.gov/show/NCT00540059 |
Completed |
AstraZeneca |
NA |
| NCT00513175 |
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00513175 |
Completed |
University of California, San Francisco |
NA |
| NCT00488878 |
Data Collection for Patients With Low Grade Ovarian Carcinoma |
https://ClinicalTrials.gov/show/NCT00488878 |
Recruiting |
M.D. Anderson Cancer Center |
2034-05-31 |
| NCT00477100 |
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer |
https://ClinicalTrials.gov/show/NCT00477100 |
Recruiting |
M.D. Anderson Cancer Center |
2020-04-30 |
| NCT00469066 |
Cone Beam CT Scanning in Lung and Bladder Cancer. |
https://ClinicalTrials.gov/show/NCT00469066 |
Completed |
AHS Cancer Control Alberta |
2009-08-31 |
| NCT00460798 |
SUTENT® In The First Line Treatment Of Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00460798 |
Completed |
Pfizer |
2009-09-30 |
| NCT00460356 |
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes |
https://ClinicalTrials.gov/show/NCT00460356 |
Completed |
Gynecologic Oncology Group |
2016-07-16 |
| NCT00453674 |
German Adrenocortical Carcinoma Registry |
https://ClinicalTrials.gov/show/NCT00453674 |
Recruiting |
University of Wuerzburg |
2023-12-31 |
| NCT00439127 |
OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation |
https://ClinicalTrials.gov/show/NCT00439127 |
Completed |
Oncology Institute of Southern Switzerland |
NA |
| NCT00388024 |
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00388024 |
Completed |
Wake Forest University Health Sciences |
2008-12-31 |
| NCT00923884 |
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer |
https://ClinicalTrials.gov/show/NCT00923884 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00341146 |
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) |
https://ClinicalTrials.gov/show/NCT00341146 |
Completed |
National Institutes of Health Clinical Center (CC) |
2006-08-20 |
| NCT00263731 |
Metabolomic Analysis of Lung Cancer |
https://ClinicalTrials.gov/show/NCT00263731 |
Recruiting |
University of Louisville |
2025-12-31 |
| NCT00218868 |
Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear |
https://ClinicalTrials.gov/show/NCT00218868 |
Completed |
Norwegian University of Science and Technology |
2006-02-28 |
| NCT00222404 |
Pharmacogenomic Study Realized on “Non-small Cell Lung Carcinoma” |
https://ClinicalTrials.gov/show/NCT00222404 |
Completed |
University Hospital, Grenoble |
NA |
| NCT00218829 |
DMSO-PDT of BCC - A 6 Year Follow up |
https://ClinicalTrials.gov/show/NCT00218829 |
Completed |
Norwegian University of Science and Technology |
2004-12-31 |
| NCT00195299 |
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck |
https://ClinicalTrials.gov/show/NCT00195299 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00188253 |
Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma. |
https://ClinicalTrials.gov/show/NCT00188253 |
Active, not recruiting |
University Health Network, Toronto |
2017-02-28 |
| NCT00178867 |
A National Registry of Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00178867 |
Completed |
Vanderbilt University |
NA |
| NCT00165126 |
Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT00165126 |
Completed |
Dana-Farber Cancer Institute |
2006-01-31 |
| NCT00160095 |
Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas |
https://ClinicalTrials.gov/show/NCT00160095 |
Completed |
Radboud University |
2010-03-31 |
| NCT00148213 |
Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT00148213 |
Completed |
University Hospital Muenster |
NA |
| NCT00026663 |
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance |
https://ClinicalTrials.gov/show/NCT00026663 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00540566 |
Optical Biopsy of Human Skin in Conjunction With Laser Treatment |
https://ClinicalTrials.gov/show/NCT00540566 |
Completed |
University of California, Irvine |
2008-06-30 |
| NCT00836342 |
Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer |
https://ClinicalTrials.gov/show/NCT00836342 |
Completed |
Massachusetts General Hospital |
2012-01-31 |
| NCT00716625 |
Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan) |
https://ClinicalTrials.gov/show/NCT00716625 |
Completed |
Pfizer |
2015-10-31 |
| NCT00005660 |
The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases |
https://ClinicalTrials.gov/show/NCT00005660 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001603 |
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System |
https://ClinicalTrials.gov/show/NCT00001603 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |